Medication info
Terakasue Chewable Tablet 5mg (Montelukast Sodium)

Terakasue Chewable Tablet 5mg (Montelukast Sodium)

Prescription medicationChewable TabletOral
Ingredient · strength
Montelukast Sodium›5.2mg / 1 tablet
Manufacturer / importer
Teragen Etex Co., Ltd.
Appearance
Pink chewable tablet, round and convex on both sides
Packaging
28 Tablets (7 Tablets/Blister × 4)
Approval status
Active

MFDS item code 201600839 · Approved 2016.02.15 · Insurance code 698503360

Summary

Main use
Prevention and ongoing treatment of asthma; relief of seasonal and perennial allergic rhinitis symptoms
Who takes it
Adults · Children
Adult dose
Take this medicine once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the time of administration should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 packet, or 1 sheet once daily in the evening. Asthma or allergic rhinitis Adults and adolescents aged 15 years and older: Administer montelukast 10 mg orally once daily.
Child dose
Children aged 6~14 years: Chew montelukast 5 mg once daily. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Chew montelukast 4 mg once daily. Administer this medicine 1 hour before or 2 hours after a meal.

Ingredients

Manufacturer
Teragen Etex Co., Ltd.

Efficacy & effects

Prevention and ongoing treatment of asthma; relief of seasonal and perennial allergic rhinitis symptoms

  • Asthma
  • allergic rhinitis symptoms
View approved original text

This medication helps prevent and manage asthma continuously. It is also used to relieve symptoms of seasonal and persistent allergic rhinitis.

How to take

Adult dose

Take this medicine once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the time of administration should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 packet, or 1 sheet once daily in the evening. Asthma or allergic rhinitis Adults and adolescents aged 15 years and older: Administer montelukast 10 mg orally once daily.

Child dose

Children aged 6~14 years: Chew montelukast 5 mg once daily. Administer this medicine 1 hour before or 2 hours after a meal. Children aged 2~5 years: Chew montelukast 4 mg once daily. Administer this medicine 1 hour before or 2 hours after a meal.

Precautions

This medication contains the artificial sweetener aspartame, so patients with the hereditary condition phenylketonuria should avoid taking it. The intake of aspartame should be limited to below the WHO recommended amount, and adults should be careful not to exceed 2.4g per day. Patients allergic to this medication or its ingredients should not take it, nor should those with lactose intolerance or specific genetic issues. This medication is not intended as a treatment for acute asthma attacks, so patients should always carry a rescue inhaler. When reducing the use of inhaled corticosteroids, consult a physician, and do not abruptly switch to another medication. If neurological or psychiatric symptoms (e.g., anxiety, depression, hallucinations) occur during treatment, inform your doctor immediately. Patients with exercise-induced asthma should not rely solely on this medication for treatment but should continue using an inhaled β-agonist and keep a rescue inhaler ready. Patients with aspirin hypersensitivity should not take this medication concurrently with aspirin or non-steroidal anti-inflammatory drugs. Rarely, serious side effects such as systemic eosinophilia or vasculitis may occur, so patients should be closely monitored. There have been no significant interactions reported when using this medication with multiple drugs; however, caution is necessary when used with certain enzyme inducers. Pregnant women should use this medication only when necessary, and nursing mothers should also be cautious when taking it. Children and the elderly can use it, but the dosage and administration method should be adjusted according to age, and safety has not been established for children under 6 months. There is no specific antidote for overdose, but general symptomatic treatment and clinical observation are necessary. This medication is sensitive to light, so it should be taken immediately after opening, and stored out of children's reach. During treatment, it is essential to follow the doctor's instructions and consult immediately if symptoms worsen or unusual reactions occur.

Side effects

  • Asthenia
  • fatigue
  • fever
  • abdominal pain
  • trauma
  • dyspepsia
  • infectious gastroenteritis
  • toothache
  • dizziness
  • headache
Show 91 more
  • nasal congestion
  • cough
  • influenza
  • rash
  • increased ALT
  • increased AST
  • pyuria
  • pharyngitis
  • sinusitis
  • nausea
  • diarrhea
  • loss of appetite
  • otitis
  • viral infection
  • laryngitis
  • (infectious) rhinitis
  • varicella
  • gastroenteritis
  • atopic dermatitis
  • acute bronchitis
  • dental infection
  • skin infection
  • myopia
  • ear pain
  • enteritis
  • eczema
  • urticaria
  • pneumonia
  • dermatitis
  • conjunctivitis
  • upper respiratory infection
  • wheezing
  • otitis media
  • tonsillitis
  • sinusitis
  • sinus headache
  • epistaxis
  • increased bleeding frequency
  • thrombocytopenia
  • hypersensitivity reaction
  • anaphylaxis
  • hepatic eosinophilic infiltration
  • aggressive behavior
  • hostility
  • restlessness
  • anxiety
  • depression
  • disorientation
  • attention disorder
  • sleep disorder
  • hallucinations
  • insomnia
  • memory impairment
  • psychomotor hyperactivity
  • sleepwalking
  • suicidal ideation
  • behavior
  • tics
  • drowsiness
  • perceptual disturbances
  • sensory decrease
  • convulsive seizure
  • palpitations
  • pulmonary eosinophilia
  • diarrhea
  • vomiting
  • pancreatitis
  • cholestatic hepatitis
  • hepatocellular liver injury
  • mixed-type liver injury
  • angioedema
  • bruise
  • erythema multiforme
  • nodular erythema
  • itching
  • urticaria
  • toxic epidermal necrolysis
  • mucocutaneous syndrome
  • arthralgia
  • muscle cramps
  • myalgia
  • enuresis
  • edema
  • systemic eosinophilia
  • vasculitic rash
  • worsening pulmonary symptoms
  • cardiac complications
  • neuropathy
  • alopecia
  • thirst
  • psychomotor agitation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air, moisture, and light. The storage temperature should be maintained between 1 and 30 degrees Celsius at room temperature to preserve its effectiveness and safety for as long as possible.

Appearance and packaging

Appearance

Pink chewable tablet, round and convex on both sides

Package unit

28 Tablets (7 Tablets/Blister × 4)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.